Back to Search Start Over

Letter: adoption of uniform nomenclature is crucial for estimating the true risk of HBV reactivation in patients treated with direct-acting antivirals for hepatitis C.

Authors :
Mücke MM
Mücke VT
Vermehren J
Source :
Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2018 Jun; Vol. 47 (11), pp. 1573-1574.
Publication Year :
2018

Subjects

Subjects :
Hepacivirus
Hepatitis B virus
Humans
Antiviral Agents
Hepatitis B, Chronic
Hepatitis C, Chronic

Details

Language :
English
ISSN :
1365-2036
Volume :
47
Issue :
11
Database :
MEDLINE
Journal :
Alimentary pharmacology & therapeutics
Publication Type :
Editorial & Opinion
Accession number :
29878415
Full Text :
https://doi.org/10.1111/apt.14653
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details